RVL Pharmaceuticals plc Long-Term Debt, Maturity, Year Two
RVL Pharmaceuticals plc had Long-Term Debt, Maturity, Year Two of $14.13 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2023-08-14
- 2023-06-30: Long-Term Debt, Maturity, Year Two $14.13M.
- 2023-03-31: Long-Term Debt, Maturity, Year Two $14.13M.
- 2022-12-31: Long-Term Debt, Maturity, Year Two $15.00M.
- 2022-09-30: Long-Term Debt, Maturity, Year Two $15.00M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2023-06-30 | $14.13M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.13M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.00M 10-K · filed 2023-03-20 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $11.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.00M 10-Q · filed 2022-05-12 |